- 如果您對該產(chǎn)品感興趣的話，可以
- 產(chǎn)品名稱：重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白
- 產(chǎn)品型號：rMusTNF RII/TNFRSF1B
- 產(chǎn)品展商：KALANG
- 產(chǎn)品文檔：無相關(guān)文檔
- 發(fā)布時間：2018-08-13
- 在線詢價
簡單介紹
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白與其它公司提供的重組蛋白不同，rMusTNF RII/TNFRSF1B蛋白產(chǎn)品為采用CFS的無細(xì)胞麥胚蛋白合成系統(tǒng)表達(dá)出來的重組蛋白，可表達(dá)出對細(xì)胞有毒性、易被蛋白酶降解的蛋白；并獲得具有良好的可溶性，并有翻譯后修飾、從而部分具有功能的蛋白.同時獨有的全自動蛋白純化技術(shù)則簡便高效，將蛋白純化過程中對蛋白的損傷降低到*小程度.重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白（全長序列）產(chǎn)品可用于Western Blot驗證、抗體制備、蛋白檢測、ELISA等試驗中.
產(chǎn)品描述
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白
|
Species
|
Murine
|
|
Accession
|
P25119
|
|
GeneID
|
21938
|
|
Source
|
Escherichia coli.
|
|
Molecular Weight
|
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白Approximately 25.3 kDa, a single non-glycosylated polypeptide chain containing 236 amino acids.
|
|
Quantity
|
5μg/20μg/1000μg
|
|
AA Sequence
|
VPAQVVLTPY KPEPGYECQI SQEYYDRKAQ MCCAKCPPGQ YVKHFCNKTS DTVCADCEAS MYTQVWNQFR TCLSCSSSCT TDQVEIRACT KQQNRVCACE AGRYCALKTH SGSCRQCMRL SKCGPGFGVA SSRAPNGNVL CKACAPGTFS DTTSSTDVCR PHRICSILAI PGNASTDAVC APESPTLSAI PRTLYVSQPE PTRSQPLDQE PGPSQTPSIL TSLGSTPIIE QSTKGG
|
|
Purity
|
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白> 97 % by SDS-PAGE and HPLC analyses.
|
|
Biological Activity
|
Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the TNF-α mediated cytotoxicity in the L-929 cells is less than 2 μg/ml, corresponding to a specific activity of > 500 IU/mg in the presence of 0.1 ng/mL of rMuTNF-α.
|
|
Physical Appearance
|
Sterile Filtered White lyophilized (freeze-dried) powder.
|
|
Formulation
|
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4.
|
|
Endotoxin
|
Less than 0.1 EU/μg of rMusTNF RII/TNFRSF1B as determined by LAL method.
|
|
Reconstitution
|
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|
重組小鼠可溶性腫瘤壞死因子受體II型/ TNFRSF1B蛋白
|
|
|
SDS-PAGE
|
|
